ROGER D. DANSEY - 13 Aug 2021 Form 4 Insider Report for Seagen Inc.

Role: Chief Medical Officer
Signature: By: /s/ Elizabeth Bekiroglu For: Roger D Dansey
Issuer symbol: N/A
Transactions as of: 13 Aug 2021
Net transactions value: -$1,565,867
Form type: 4
Filing time: 13 Aug 2021, 21:39:53 UTC
Previous filing: 21 Jun 2021
Next filing: 18 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SGEN	Common Stock	Sale	$1,550,142	-9,900	-12%	$156.58	74,535	13 Aug 2021	Direct	F1, F2
transaction	SGEN	Common Stock	Sale	$15,725	-100	-0.13%	$157.25	74,435	13 Aug 2021	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects sales of common stock executed in multiple transactions at prices ranging from $156.25 to $157.23 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F2	Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.

Content

Reflects sales of common stock executed in multiple transactions at prices ranging from $156.25 to $157.23 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.